04 Apr 2023 Wellbeing

£200 grants for people affected by leukaemia once again available

Leukaemia UK and Leukaemia Care have this month relaunched the ‘Cost of Living Fund’, providing financial grants of £200 to patients with leukaemia, myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), whose lives have been impacted by the ongoing cost of living crisis. 

Applications are open now for grants of up to £200 provided by the Leukaemia UK and Leukaemia Care ‘Cost of Living Fund’. Over £168,000 was given to families affected by leukaemia, MDS or an MPN in 2022. Together, Leukaemia UK and Leukaemia Care hope that the relaunch of this fund will provide much-needed support during one of the most difficult times of a person’s life. 

Fiona Hazell, Chief Executive of Leukaemia UK, said: 

“The relaunch of the Cost of Living with Leukaemia Fund will help to improve the lives of more people across the UK living with leukaemia. The emotional and physical challenges of leukaemia are profound, and the diagnosis often brings additional financial pressures during what is already one of the most difficult times of a person’s life. The Cost of Living with Leukaemia Fund will make a tangible difference to their lives, and we are very grateful to our supporters for making this relaunch possible.” 

Please visit the Leukaemia Care website to find out more. 

Related posts

Non-existent awareness of leukaemia symptoms “extremely worrying” – say leading UK leukaemia charities, as they launch memorable new campaign to get people “parroting on” about the symptoms

24 August 2022

Non-existent awareness of leukaemia symptoms “extremely worrying” – say leading UK leukaemia charities, as they launch memorable new campaign to get people “parroting on” about the symptoms

People over 55 also underestimate their risk, thinking that leukaemia is a childhood disease. Only 11% of over 55s thought that they had the greatest risk of leukaemia[1], whereas in…

Widespread coverage of new leukaemia therapy shows promise in first trial patient

12 December 2022

Widespread coverage of new leukaemia therapy shows promise in first trial patient

As you may have seen in the news over the weekend, a clinical trial investigating a new leukaemia treatment has shown promising results. As part of the trial, funded by…

John Goldman Fellowship awarded to Dr Pramila Krishnamurthy

29 November 2021

John Goldman Fellowship awarded to Dr Pramila Krishnamurthy

Leukaemia UK is proud to announce Dr Pramila Krishnamurthy of King’s College Hospital and King’s College London as a Leukaemia UK John Goldman Fellow co-funded by Rosetrees Trust. Dr Krishnamurthy will be using the fellowship to better understand why some leukaemia patients relapse following a stem cell transplant, and how donor lymphocyte infusion can help prevent this.

Statement from Leukaemia UK on the death of Her Majesty Queen Elizabeth II

8 September 2022

Statement from Leukaemia UK on the death of Her Majesty Queen Elizabeth II

On behalf of the Leukaemia UK team, Chair of Trustees, Chris Corbin OBE, has made the following statement: “We are extremely saddened to hear the news of the death of…